Pbt2 Program.pdf -

Safety, tolerability, and efficacy of PBT2 in Huntington's disease

PBT2 is a Metal-Protein Attenuating Compound (MPAC) designed by Alterity Therapeutics to treat neurodegenerative disorders like Alzheimer’s and Huntington’s by redistributing copper and zinc to restore neuronal health. Clinical trials have shown that PBT2 is generally safe and, in early studies, showed potential in improving executive function and reducing amyloid-beta levels. For comprehensive details on PBT2, including clinical trial data, visit Alzforum . PBT2 Program.pdf